ALK mutations conferring differential resistance to structurally diverse ALK inhibitors. [electronic resource]
Producer: 20120427Description: 7394-401 p. digitalISSN:- 1557-3265
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- pharmacology
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- Crizotinib
- Drug Resistance, Neoplasm -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Microtubule-Associated Proteins -- genetics
- Mutation
- Neuroblastoma -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Polymorphism, Single Nucleotide
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Pyrimidines -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Serine Endopeptidases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.